Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04972552

Watermelon/UBIQuinone Study

Watermelon/UBIQuinone Study (WUBI-Q Trial)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of the proposed pilot trial is to determine the feasibility and safety of increasing watermelon consumption, with or without coenzyme Q supplementation in patients after kidney transplantation on kidney function and urinary protein excretion.

Detailed description

While many observational studies have examined the effects of consuming watermelon in patients without chronic kidney disease, there have been few studies on the consumption of a diet high in watermelon as a means of improving kidney function or reducing protein in the urine. Coenzyme Q is also recognized as a supplement that has benefits for heart health and has anti-oxidative effects, but whether it could be used to improve kidney function or reduce protein in the urine has not been thoroughly examined, especially in the kidney transplant population. The objective of the proposed pilot trial is to determine the feasibility and safety of increasing watermelon consumption, with or without coenzyme Q supplementation in patients after kidney transplantation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcoenzyme Q10Participants will take 800-1200 mg of coenzyme Q10 capsule per day
OTHERWatermelon dietParticipants will be asked to eat watermelon at a minimum of one meal per day 3-5 days a week
OTHERUsual DietParticipants will be asked to eat a usual diet but not eat any watermelon as part of their usual diet
OTHERPlaceboParticipants will be asked to take 800-1200 mg of a placebo capsule per day

Timeline

Start date
2021-11-15
Primary completion
2025-12-30
Completion
2026-06-30
First posted
2021-07-22
Last updated
2025-07-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04972552. Inclusion in this directory is not an endorsement.